01 — At a Glance
The Goldman Sachs of Indian Ratings (But More Profitable)
- 52-Week High / Low₹6,330 / ₹3,894
- FY25 Revenue (Full Year)₹3,649 Cr
- FY25 PAT (Full Year)₹766 Cr
- Full-Year EPS (FY25)₹105
- Q4 EPS₹33.02
- Book Value₹415
- Price to Book10.1x
- Dividend Yield0.60%
- Debt / Equity0.10x
- Return 3 Months-5.09%
Market Commentary: CRISIL delivered FY25 with ₹3,649 crore revenue (+11.9% YoY), ₹766 crore PAT (+12.0% YoY), and a P/E of 39.8x. That’s nearly 1.3x the financial services median. Yet the stock has spent the last 3 months going backwards (-5.09%). Investors are pricing in future growth dreams, not past execution. And boy, are those dreams expensive.
02 — Introduction
How to Run a Monopoly Without Admitting It’s One
Let’s talk about CRISIL. If Moody’s is the godfather of global ratings, then CRISIL is the godson who built his own throne in India — and then got acquired by S&P Global at a premium that would make any founder blush. Yes, S&P Global owns 67% of this. Which means you’re investing in an American conglomerate’s Indian playbook wrapped in a Mumbai-listed ticker.
The business model is almost laughable in its simplicity. Every corporate in India that wants to borrow money needs a credit rating. Not wants. Needs. It’s like oxygen for the debt capital markets. CRISIL rates them. Banks listen. Investors trust. Rinse, repeat. In 2025, they did this for 35,000+ entities rated cumulatively and maintain 1,150+ live new bank loan ratings assigned in Q4 alone. That’s not a business line — that’s a regulatory-backed cash register with a fancy name.
But the real money? It comes from research and analytics. 65% of revenues. Global banks, hedge funds, PE players, and asset managers all pay CRISIL for intelligence about Indian markets and their own portfolio risk. Greenwich Associates (acquired 2020) sells sell-side benchmarking to Wall Street titans. Coalition sells CIB intelligence to investment banks. Crisil Integral IQ is their homegrown risk analytics play. One company, four revenue streams, all locked in by high switching costs and brand moat that took 38 years to build.
FY25 was a masterclass in controlled growth. 12% PAT expansion. 11.9% revenue growth. OPM stabilized at 30%. And a final dividend of ₹28 per share, bringing the full-year payout to ₹61 per share. They’re literally returning capital faster than they’re earning it — which is a different kind of flex.
Founder DNA (March 2025): “CRISIL Ratings maintained its leadership in corporate bond ratings. Revenue grew 14.3% in Q4 and 15.7% for full FY25” — Management concall. Translation: The core business is humming. Everything else is gravy.
03 — Business Model: WTF Do They Even Do?
Four Pillars of Opinionated Monopoly
CRISIL operates across four distinct businesses, each with fortress-like economics:
1. Ratings Services (28% of revenue, 51% of profit): They rate corporate bonds, bank loans, and structured products. The margin is disgusting — 44.3% segment margin in FY25. A 10 crore rated entity pays them once. They get surveillance revenue every year thereafter. It’s like a Netflix subscription, except your bank actually listens to their opinions. The separation into a wholly owned subsidiary (CRISIL Ratings Ltd) happened for SEBI regulations, but operationally it’s still the heart.
2. Research, Analytics & Solutions (65% of revenue, 49% of profit): This is four sub-businesses pretending to be one. (a) India Research covers 77 sectors, serves 1,200+ clients, and basically owns the market for economy and industry intelligence. (b) Global Research works for 140+ financial institutions across Americas, Europe, APAC, and the Middle East — arbitraging India expertise for global fees. (c) Coalition Greenwich (acquired 2020) is the benchmark for corporate banking and wealth management performance. (d) Crisil Integral IQ sells risk and credit analytics to buy-side and financial institutions. Q4 FY25: ₹791 crore revenue, 26.2% margin. The margin is lower because it’s subscription + project work, not pure surveillance.
3. Advisory Services (7% of revenue): Infrastructure advisory, regulatory consulting, programme management. It’s where CRISIL sprinkles its brain juice across government projects and private infrastructure development. High-touch, low-volume, but decent margins.
Geographic Mix: 41% North America, 28% India, 23% Europe, 8% Rest of World. The company is truly global, but 86% of the 4,700-person workforce sits in India — arbitraging salaries, time zones, and cost structure like a true India-first SaaS play.
Ratings Margin44.3%FY25 Segment
Research Margin22.0%FY25 Segment
ROCE Overall34.6%Industry Leading
Dividend Payout58%FY25
The Moat: Every bank in India rating a loan checks CRISIL’s view. Most don’t even disagree — they just follow. That’s not persuasion. That’s institutional dependence. Try switching to the next guy, and suddenly your entire credit decision framework changes. Regulators won’t let you rank them equal. Credit analysis teams know CRISIL’s analysts’ quirks. Switching is a nightmare. That’s a moat.
💬 Quick one: Do you think AI-powered credit ratings will disrupt CRISIL’s model in 5 years, or is the regulatory moat too thick to crack?
04 — Financials Overview
Q4 FY25 & Full Year: The Numbers
Result type: Full Year Results | FY25 EPS: ₹105 | Q4 EPS: ₹33.02 | P/E Recalculated: 39.8x
| Metric (₹ Cr) |
Q4 FY25
Dec 2025 |
Q4 FY24
Dec 2024 |
Q3 FY25
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 1,082 | 913 | 911 | +18.5% | +18.7% |
| Operating Profit | 340 | 287 | 263 | +18.5% | +29.3% |
| OPM % | 31% | 31% | 29% | Flat | +200 bps |
| PAT | 242 | 225 | 193 | +7.5% | +25.4% |
| EPS (₹) | 33.02 | 30.72 | 26.41 | +7.5% | +25.0% |
A Word on P/E Calculation: FY25 full-year EPS = ₹105. CMP = ₹4,174. P/E = 39.8x (as shown in screener). This is trading at a 33% premium to the 30x financial services sector median. The justification? High ROCE at 34.6%, recurring revenue models, and S&P Global backing. The criticism? A 40x P/E is pricing in perfection — which means any stumble below 10% growth becomes a 15%+ correction. Q4 showed 18.5% revenue growth and 7.5% PAT growth YoY. The narrative is that management beat expectations. The question is whether they can sustain 15%+ CAGR from a ₹3,649 crore revenue base. Spoiler alert: That becomes progressively harder.
05 — Valuation: Fair Value Range
What’s a Monopoly Subscription Service Actually Worth?
Join 10,000+ investors who read this every week.
